编辑的转移RNAs (ACE-tRNAs) 编码为治疗性的非病毒最小DNA载体
Joseph J Porter1, Wooree Ko1, Emily G Sorensen1
1Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, United States.
Nucleic acids research
|February 5, 2026
概括
通过小DNA微载体传递的无稽之谈抑制器抗编辑转移RNA (ACE-tRNA) 为遗传疾病提供了一个有前途的治疗策略. 与传统方法相比,这种方法表明生物可用性得到改善,免疫反应减少.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 治疗方法 治疗方法
背景情况:
- 无意义的突变,由过早终止子 (PTCs) 引起,约占遗传疾病的11%.
- 无稽之谈抑制剂抗编辑转移RNAs (ACE-tRNAs) 是纠正PTCs的一种治疗策略.
- 目前使用病毒载体或RNA-脂质纳米粒子的传递方法存在缺点.
研究的目的:
- 为了评估小DNA迷你载体在ACE-tRNA传递中的有效性.
- 评估ACE-tRNA微载体对无意义突变疾病的治疗潜力.
主要方法:
- 开发和测试线性DNAACE-tRNA载体,其最小的基因对为200个 (bp).
- 在细胞和ex vivo模型中评估ACE-tRNA微载体.
- 微载体与常规等离子体DNA载体的比较.
主要成果:
- 线性DNAACE-tRNA载体有效地抑制了CFTR和REP1基因中的无意义突变.
- ACE-tRNA微载体显示了改善的生物可用性,降低了先天免疫负担,以及优越的生物稳定性.
- 这些结果与传统的等离子体DNA载体相比观察到.
结论:
- 小型DNA迷你载体对于传递ACE-tRNAs是有效的.
- ACE-tRNA微载体代表了一种有前途的,可能更安全,更稳定的治疗方法,用于由无意义突变引起的遗传疾病.
相关概念视频
Transfer RNA Synthesis
13.4K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
13.4K
siRNA - Small Interfering RNAs
18.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.7K
RNA Editing
9.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.9K
lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
piRNA - Piwi-interacting RNAs
7.7K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
From DNA to Protein
22.4K
The flow of genetic information in cells from DNA to mRNA to protein is described by the central dogma, which states that genes specify the sequence of mRNAs, which in turn specify the sequence of amino acids making up all proteins. The decoding of one molecule to another is performed by specific proteins and RNAs. Because the information stored in DNA is so central to cellular function, it makes intuitive sense that the cell would make mRNA copies of this information for protein synthesis...
22.4K


